@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns1:include . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:30.142079"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "dexamethasone , vitamin D , tocilizumab and sarilumab , chloroquine , hydroxychloroquine , azithromycin , adalimumab and tetrandrine ," . rdf:OBJECT-POSITION rdfs:label "(41, 47)" . rdf:PREDICATE rdfs:label "including" . rdf:PREDICATE-POSITION rdfs:label "105" . rdf:SUBJECT rdfs:label "the potential Treg-boosting effect of" . rdf:SUBJECT-POSITION rdfs:label "(41, 47)" . rdf:Statement rdfs:label "Furthermore, the potential Treg-boosting effect of therapeutic agents used in the treatment of COVID-19, including dexamethasone, vitamin D, tocilizumab and sarilumab, chloroquine, hydroxychloroquine, azithromycin, adalimumab and tetrandrine, is discussed." . rdfs:ABSTRACT-UID ns2:50 "mjrr9vvj" . rdfs:TRIPLE-UID ns3:mjrr9vvj-TRIPLE-ABSTRACT-3 "mjrr9vvj-TRIPLE-ABSTRACT-3" . rdfs:label "vitamin" . rdfs:label "effect" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }